Shots:
- OcuSciences has received the US FDA clearance for OcuMet Beacon, a non-invasive confocal scanning ophthalmoscope designed for infrared & autofluorescence imaging of the human retina, with or without the use of a mydriatic agent
- Peer-reviewed clinical studies have showed favorable safety & clinical utility of the OcuMet Beacon, with dozen new studies presented at ARVO 2025, highlighting expansion of its clinical applications
- OcuMet Beacon captures natural eye fluorescence & uses advanced software to visualize functional image signatures for fast, safe, & contact-free imaging in minutes, plus it can be easily integrated into routine exams without dyes, injections, or discomfort
Ref: Businesswire | Image: OcuSciences
Related News:- Teleflex’s QuikClot Control+ Hemostatic Device Receives the US FDA’s 510(k) Clearance to Temporary Control All Bleeding Grades
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
